Form 4: Bionano Genomics General Counsel Reports Routine Stock Transaction for Tax Withholding

Bionano Genomics' General Counsel, Jonathan V. Dixon, reported a routine disposition of 25 shares of common stock to cover tax obligations upon the vesting of Restricted Stock Units.

Summary

• Jonathan V. Dixon, General Counsel of Bionano Genomics, Inc. (BNGO), reported a transaction on June 3, 2025.
• The transaction involved the disposition of 25 shares of Bionano Genomics common stock at a price of $3.69 per share.
• This disposition was due to the withholding of shares by the Issuer to satisfy tax withholding obligations upon the settlement of an RSU award that vested on June 3, 2025.
• The RSU award, which led to this vesting, was originally granted on June 3, 2024.
• Following this transaction, Mr. Dixon directly beneficially owns 269 shares of Bionano Genomics common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine tax withholding related to RSU vesting, which is a common occurrence for executive compensation and does not indicate a significant positive or negative sentiment for the company's operations or financial health.

Positives

• The transaction indicates the vesting of Restricted Stock Units (RSUs) for Jonathan V. Dixon, which represents a component of his compensation and a positive event for the employee.

Negatives

• Jonathan V. Dixon's direct beneficial ownership of Bionano Genomics common stock decreased by 25 shares due to the withholding for tax obligations.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing reports a routine insider stock transaction related to executive compensation and does not provide broader industry context or trends.

Stakeholder Impact

• Minimal impact on shareholders due to the very small number of shares involved (25 shares) in this routine transaction.
• Positive for the employee (Jonathan V. Dixon) as it represents the realization of RSU compensation.

Key Dates

Keywords

Bionano Genomics, BNGO, Form 4, Insider Transaction, Stock Transaction, RSU, Restricted Stock Unit, Tax Withholding, Jonathan V. Dixon, Beneficial Ownership